Business Wire

RGI Expands Its Digital Insurance Proposition With the Acquisition of D4Next

30.9.2026 10:00:00 CEST | Business Wire | Press Release

Share

RGI, the leading provider of digital solutions for the European insurance industry, announces the acquisition of D4Next, an insurance technology company specializing in solutions that connect insurance products, distribution channels and digital processes, powered by innovative AI models.

The acquisition broadens RGI’s ability to support insurers in addressing one of the key challenges facing the industry: how to accelerate business and technological innovation while progressively evolving an increasingly complex technology landscape.

Supporting the evolution of insurance at the pace of the market

As insurers continue to invest in new products, digital channels, distribution models and more intelligent processes, the ability to introduce innovation progressively, and connect new capabilities with the technologies already supporting the business, is becoming increasingly important.

With the acquisition of D4Next, RGI expands its proposition with capabilities designed to support this evolution across the insurance value chain.

“The future of insurance technology is not about choosing between core platforms and agility. It is about making the technology landscape work together to support faster business innovation,” said Gianni Camisa, RGI Group CEO. “The acquisition of D4Next boosts RGI’s ability to help insurers evolve their technology progressively, combining our expertise in insurance platforms with new capabilities that can accelerate innovation across digital, products and distribution.”

Enabling digital distribution beyond the core

Founded in 2021 by Vito Rocca and Davide Scaravaggi, Christophe Quesne joined the company’s shareholding structure in 2024 as part of the establishment of its French entity.

D4Next brings to RGI a technology platform and expertise focused on enabling insurers to bring new commercial offers and services to market with greater speed and flexibility.

Its YOGA platform acts as an intelligent layer that integrates with existing insurance systems and extends their capabilities, with a particular focus on digital distribution, channel configuration, to support commercial offer configuration across distribution channels, channel strategy management, real-time business event processing and analytics, hybrid offerings combining insurance and non-insurance products, and omni-channel interactions across mobile, phone and intermediary channels. These capabilities complement RGI’s existing insurance technology proposition, broadening the ways in which the Group can support insurers as they evolve their distribution strategies and business models.

In particular, YOGA enables insurers to decouple commercial offer configuration from the underlying technical insurance product, connect different core systems and channels, and introduce new services and workflows.

YOGA is already fully integrated with RGI PASS Platform and the very positive experience of customers already running the integrated suite demonstrates the value of the joint proposition.

RGI and D4Next will further expand their cooperation in the markets already served by RGI and are already actively pursuing opportunities in France, where D4Next has an established presence.

From technology evolution to business agility

The acquisition reflects RGI’s commitment to helping insurers turn technology evolution into tangible business outcomes.

By combining RGI’s insurance technology expertise with D4Next’s agility capabilities, the Group can help insurers connect channels and services, accelerate digital initiatives and extend their core insurance platforms with new capabilities.

YOGA also extends these capabilities with agentic AI applications that support digital interactions with customers across insurance processes such as underwriting, claims, and customer service.

“Joining RGI marks an important step in D4Next’s growth. We share a common vision of how technology can help insurers accelerate business innovation, said Davide Scaravaggi D4Next’s CEO, “Becoming part of RGI gives us the opportunity to contribute to a broader proposition, combining our capabilities with RGI’s technology, insurance expertise and international presence.”

A growing platform for the insurance market

D4Next has a team of more than 20 professionals and operates across Italy and France. Over the last three years, the company has built a customer base of 16 clients.

The acquisition further strengthens RGI’s ability to support insurers across different stages of technology and business evolution, bringing together established insurance platform expertise with new capabilities for agility, digital transformation and intelligent process innovation.

About RGI

RGI is the leading European provider of insurance core platforms for the P&C, Life and Claims sectors. With hundreds of clients across dozens of countries in the EMEA region, RGI combines deep insurance and technology expertise, modular digital solutions, and a pragmatic, results-driven approach, bringing together strong local capabilities with a pan-European vision. For 40 years, RGI has been driving innovation in the insurance industry, helping insurers manage complexity, accelerate process evolution, and address digital transformation in a concrete and sustainable way.

Web: www.rgigroup.com

Linkedin: https://www.linkedin.com/company/rgi-group/

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008181360/en/

Contacts

Elena Monti
marketing@rgigroup.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 14:02:00 CEST | Press Release

Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty Texture Editwas designed to resonate with a global cultural beauty movement captivating the next gene

GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press Release

GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005273717/en/ SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products The acquisition of SOFIE Biosciences establishes a footprint for GE HealthCare in the time-critical ‘final mile’ of U.S. PET radiopharmaceutical supply, while also enabling PDx to participate in other high growth areas outside its own product portfolio. With a U.S. network of 15 CMO sites operating 21 cyclotrons, and a theranostics

Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press Release

Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking expertise with Solos' proprietary dealcoholization and patented aroma recovery technology. With 30 years of experience in producing alcohol-free sparkling wines, Henkell Fre

Croma-Pharma Expands Its Portfolio in Canada With saypha ® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press Release

Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia

Anaeco Secures Strategic Investment from Momentum Global Ventures to Accelerate Commercial Deployment5.10.2026 12:00:00 CEST | Press Release

Anaeco, Inc., a clean technology company developing systems to destroy harmful and difficult-to-abate gases, today announced a strategic investment from Momentum Global Ventures. The investment supports Anaeco as it moves from technology development and validation to commercial deployment across three initial markets: anesthetic gases, refrigerants, and semiconductor manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005546122/en/ Anaeco’s technology exploits atmospheric chemistry to destroy harmful, high-impact gases, including HFCs, PFAS, anesthetic gases, N2O, and other difficult-to-abate emissions at their source. By accelerating processes that naturally transform pollutants, its modular technology provides a practical, scalable approach to emissions that are difficult or costly to manage conventionally. Initial Commercial Verticals Anesthetics: Destroying anesthetic gases generated in healthcare environmen

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye